| Current Price | $39.41 | Mkt Cap | $6.3B |
|---|---|---|---|
| Open | $39.85 | P/E Ratio | 0.00 |
| Prev. Close | $39.91 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $39.27 - $39.99 | Volume | 631,904 |
| 52-Wk Range | $23.77 - $58.72 | Avg. Daily Vol. | 2,227,605 |
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.
| Current Price | $39.41 | Mkt Cap | $6.3B |
|---|---|---|---|
| Open | $39.85 | P/E Ratio | 0.00 |
| Prev. Close | $39.91 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $39.27 - $39.99 | Volume | 631,904 |
| 52-Wk Range | $23.77 - $58.72 | Avg. Daily Vol. | 2,227,605 |
The best Bull and Bear pitches based on recency and number of recommendations.
Nuplazid is the first drug approved for the treatment of PD psychosis. This market represents a 2-3B peak in sales. If Pimavanserin successfully expands its label to Alzheimer psychosis, Alzheimer agitation, schizo IRAT, then you have a company with… More
This article does a good job of laying out the bear case: http://seekingalpha.com/article/4015176-acadias-nuplazid-blockbuster-drug-imaginedThe market may turn out to be smaller than expected, especially with the black box warning ("Side effects… More
Read the most recent pitches from players about ACAD.
Recs
LifeScientist
(< 20)
Submitted: 7/2/2020 3:08:37 PM :
Start Price:
$52.08
NASDAQ:ACAD Score:
-31.26
The principal pipieline drug Nuplazid seeking fda approval is already market for Parkinson’s patients. Wow, my own Mom could benefit! ....we’ve been seeking a drug that would help her hallucinations w dementia. sNDA on dementia now....hope it works and is covered by insurance!
Recs
wrciii
(73.01)
Submitted: 6/5/2020 6:30:37 AM :
Start Price:
$46.55
NASDAQ:ACAD Score:
-20.96
Salveen R + Haen
Recs
NHWeston102
(78.94)
Submitted: 5/2/2020 2:10:25 PM :
Start Price:
$47.37
NASDAQ:ACAD Score:
-34.37
Leading dementia treatment candidates.
Find the members with the highest scoring picks in ACAD.
jamrod02 (58.97) Score: +4,870.36
The Score Leader is the player with the highest score across all their picks in ACAD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| jamrod02 | 58.97 | 12/20/2010 |
|
5Y | $0.77 | +5,040.28% | +169.91% | +4,870.36 | 0 Comment | |
| noobtery | < 20 | 10/28/2010 |
|
5Y | $0.83 | +4,668.07% | +183.04% | +4,485.04 | 0 Comment | |
| Hornet41 | 56.19 | 12/22/2010 |
|
5Y | $0.90 | +4,296.73% | +168.11% | +4,128.63 | 0 Comment | |
| Ruckwerts | 46.10 | 12/1/2011 |
|
3Y | $0.93 | +4,155.38% | +169.63% | +3,985.74 | 0 Comment | |
| dsherid2 | < 20 | 11/30/2011 |
|
1Y | $1.03 | +3,742.61% | +170.78% | +3,571.82 | 0 Comment | |
| Smog79 | 21.25 | 8/12/2010 |
|
3W | $1.04 | +3,705.29% | +209.75% | +3,495.54 | 0 Comment | |
| drmanand | 55.98 | 7/14/2010 |
|
1Y | $1.11 | +3,465.96% | +207.77% | +3,258.19 | 1 Comment | |
| smallandmidcap | 93.92 | 8/10/2010 |
|
5Y | $1.13 | +3,402.21% | +200.29% | +3,201.92 | 0 Comment | |
| dmkj50 | < 20 | 10/27/2011 |
|
5Y | $1.17 | +3,282.19% | +162.97% | +3,119.22 | 0 Comment | |
| tappo3833 | 91.99 | 1/3/2011 |
|
1Y | $1.19 | +3,225.63% | +165.50% | +3,060.13 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
